Literature DB >> 28692418

Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes Among the Han Chinese.

Xuan Gao1, Youxin Wang2, Minglin Lang3, Li Yuan1, Albert Stuart Reece4, Wei Wang2,5.   

Abstract

Heroin and drug dependence are major contributors to global health burden worldwide, but their underlying mechanisms remain elusive and may vary from population to population. Reward- and memory-related candidate genes dopamine D2 receptor (DRD2) and brain-derived neurotrophic factor (BDNF), as well as the opioid receptor genes (OPRM1, OPRD1, and OPRK1), have been implicated in drug dependence, but relatively little is known on their contributions to heroin dependence in populations worldwide. Hence, we evaluated the contributions of the above five candidate genes in heroin dependence and several important related endophenotypes (the onset age of heroin use and subjective response to first heroin use), at single single-nucleotide polymorphism as well as haplotype levels, in a Han Chinese population sample. We genotyped 546 unrelated and heroin-dependent subjects for the candidate genes noted, and 228 sex- and age-matched unrelated controls. The G allele of rs4654327 (OPRD1), DRD2 haplotype block CCGCCGTT (rs6277-rs1076560-rs2283265-rs2734833-rs2075652-rs1079596-rs4436578-rs11214607), and OPRD1 haplotypes TACG (rs6669447-rs2236857-rs508448-rs4654327), CG (rs508448-rs4654327), and TG (rs6669447-rs4654327) were significantly associated with heroin dependence phenotype. Homozygotes AA at rs6265 (BDNF), TT at rs16917234 (BDNF), and CC at rs508448 (OPRD1) also appeared as risk factors for the endophenotype earlier age of onset for heroin use. Two OPRM1 haplotypes, AG (rs1799971-rs1381376) and AT (rs1799971-rs3778151), were observed as potential protective factors. These emerging findings contribute to the literature on genetic biomarkers of drug dependence and related endophenotypes, and call for replication in independent population.

Entities:  

Keywords:  BDNF; DRD2; Han Chinese; OPRD1; OPRK1; OPRM1; genetic association study

Mesh:

Substances:

Year:  2017        PMID: 28692418     DOI: 10.1089/omi.2017.0057

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


  8 in total

1.  Effects of OPRM1 and DRD2 on brain structure in drug-naïve adolescents: Genetic and neural vulnerabilities to substance use.

Authors:  Giorgia Picci; Diana H Fishbein; John W VanMeter; Emma J Rose
Journal:  Psychopharmacology (Berl)       Date:  2021-11-24       Impact factor: 4.530

2.  Genetic polymorphisms in the opioid receptor delta 1 (OPRD1) gene are associated with methadone dose in methadone maintenance treatment for heroin dependence.

Authors:  Chiu-Ping Fang; Sheng-Chang Wang; Hsiao-Hui Tsou; Ren-Hua Chung; Ya-Ting Hsu; Shu Chih Liu; Hsiang-Wei Kuo; Tung-Hsia Liu; Andrew C H Chen; Yu-Li Liu
Journal:  J Hum Genet       Date:  2020-01-07       Impact factor: 3.172

3.  Identification of a sex-stratified genetic algorithm for opioid addiction risk.

Authors:  David Bright; Anna Langerveld; Susan DeVuyst-Miller; Claire Saadeh; Ashley Choker; Elisabeth Lehigh; Stephanie Wheeler; Ahed Zayzafoon; Minji Sohn
Journal:  Pharmacogenomics J       Date:  2021-02-15       Impact factor: 3.550

4.  OPRD1 SNPs associated with opioid addiction are cis-eQTLs for the phosphatase and actin regulator 4 gene, PHACTR4, a mediator of cytoskeletal dynamics.

Authors:  Orna Levran; Matthew Randesi; Miriam Adelson; Mary Jeanne Kreek
Journal:  Transl Psychiatry       Date:  2021-05-25       Impact factor: 6.222

5.  Dopamine Receptor DRD2 Gene rs1076560, Personality Traits and Anxiety in the Polysubstance Use Disorder.

Authors:  Aleksandra Suchanecka; Jolanta Chmielowiec; Krzysztof Chmielowiec; Jolanta Masiak; Olimpia Sipak-Szmigiel; Mariusz Sznabowicz; Wojciech Czarny; Monika Michałowska-Sawczyn; Grzegorz Trybek; Anna Grzywacz
Journal:  Brain Sci       Date:  2020-04-30

6.  Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with Opioid Use Disorder in West Virginia.

Authors:  Laura R Lander; Vincent Setola; Shane W Kaski; Stephan Brooks; Sijin Wen; Marc W Haut; David P Siderovski; James H Berry
Journal:  J Opioid Manag       Date:  2019 Mar-Apr

7.  The opioid crisis: a contextual, social-ecological framework.

Authors:  Mohammad S Jalali; Michael Botticelli; Rachael C Hwang; Howard K Koh; R Kathryn McHugh
Journal:  Health Res Policy Syst       Date:  2020-08-06

Review 8.  Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.

Authors:  Jamie A Burns; Danielle S Kroll; Dana E Feldman; Christopher Kure Liu; Peter Manza; Corinde E Wiers; Nora D Volkow; Gene-Jack Wang
Journal:  Front Psychiatry       Date:  2019-09-18       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.